PMC7425316_01
(a) Preoperative lateral and (b) posterior views of keloid with ulceration and necrosis.
10.1177_2050313X20936033-fig1.jpg
PMC7425316_01_10.1177_2050313X20936033-fig1.jpg
fig1-2050313X20936033
He suffered from significant decreased quality of life due to social stigma, pain, ulceration from minor trauma, infection, and restriction in lateral neck rotation and flexion (Figure 1(a) and (b)).
Keloid prior to fractional laser-assisted delivery of topical TAC.
10.1177_2050313X20936033-fig2.jpg
PMC7425316_01_10.1177_2050313X20936033-fig2.jpg
fig2-2050313X20936033
He also had restriction in lateral movement of his neck, and his wound was firm to palpation (Figure 2).
Keloid scar following six fractional laser-assisted topical TAC treatments.
10.1177_2050313X20936033-fig3.jpg
PMC7425316_01_10.1177_2050313X20936033-fig3.jpg
fig3-2050313X20936033
The patient suffered from no further ulceration of the skin during this fractional laser-assisted drug delivery. The patient remains pleased with the functional and cosmetic appearance of his scar 22 months from his last such treatment and has not had recurrence of the keloid 47 months from his excision (Figure 3).